OverviewSuggest Edit

Nuritas is a company revolutionizing the discovery of novel and natural active ingredients with scientifically proven health benefits. Our disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. This means that for the first time Nuritas can rapidly and efficiently provide access to the most health-benefiting components within foods, called bioactive peptides. Our life-changing peptides, the subject of pending patent applications, provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, skin anti-aging solutions, and the potential management of blood sugar levels for type 2 diabetics. Put in a nutshell, the company discovers and unlocks ingredients from food sources in a completely unique way, providing natural, sustainable and scientifically proven health solutions. Our dynamic peptides have a vast range of applications in multiple industries including functional and medical foods, pharmaceuticals, dietary supplements, and cosmetics and personal care.
HQDublin 2, IE

Latest Updates

Employees (est.) (Nov 2019)56(+2%)

Key People/Management at Nuritas

Emmet Browne

Emmet Browne

Greg Staffor

Greg Staffor

Nora Khaldi

Nora Khaldi

Founder and CSO
Show more

Nuritas Office Locations

Nuritas has an office in Dublin 2
Dublin 2, IE (HQ)
Hays House, 2 Dawson St
Show all (1)

Nuritas Financials and Metrics

Summary Metrics

Founding Date


Nuritas total Funding

$27.4 m

Nuritas latest funding size

$18.90 m

Time since last funding

2 years ago

Nuritas investors

Nuritas's latest funding round in December 2017 was reported to be $18.9 m. In total, Nuritas has raised $27.4 m
Show all financial metrics

Nuritas Online and Social Media Presence

Embed Graph

Nuritas News and Updates

Irish biotech company Nuritas lands $20 mln Series A

Irish biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Dutch biotech company Nuritas lands $20 mln Series A

Dublin-based biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food, which it claims is 500 times faster than current technology. “Our artificial in…

Nuritas Blogs

Nuritas Announces Launch of US Operations & adds to Executive Team

DUBLIN, Ireland  – Global leader in the use of artificial intelligence to discover new drugs announces a new US head office based in Boston and the associated appointment of two key new executives, veteran biopharma executive Arthur Hiller and Tim Considine from Recursion Pharma.  This new office wi…

2019 Pharma Industry Awards: A message from Emmet Browne, CEO

Nuritas is honoured to have been shortlisted for a grand total of three awards in this evenings 2019 Pharma Industry Awards. Our Categories include: Biotech Company of the Year Innovation of the Year Pharma Company of the Year (SME) Although we will not know until this evening how we have fared, it …

Nuritas reveals new Longevity peptides

Founder and CSO of Nuritas, Dr Nora Khaldi, was recently interviewed by Longevity.Technology. She revealed that Nuritas is making significant strides in the longevity arena with the discovery of peptides that are showing significant promise for the treatment pre-diabetes and NASH. “It’s all about st…

Nuritas shortlisted for 3 Pharma Industry Awards

We are honoured to be shortlisted for not one, but three awards at the upcoming Pharma Industry Awards on 24th October 2019 – Pharma Company of the Year SME, Biotech Company of the Year and Innovation of the Year. Founded in 2014, the recognise and celebrate the most original and innovative individu…

Nuritas Presenting at Digital Summit Dublin 2019

Nuritas is proud to be participating in the Digital Summit Dublin, later today at the Convention Centre. “The Digital Summit Dublin 2019 is a one-day event featuring a number of preeminent international speakers who will discuss the development of digital technologies and maximising their use for th…

Nuritas and Stonehaven Incubate Sign Partnership Agreement to bring Artificial Intelligence to Animal Health

DUBLIN, Ireland / Andermatt, Switzerland (July 25, 2019) – Nuritas and Stonehaven Incubate have announced a new collaboration which will see them join forces as part of a newly created joint venture. This world leading partnership will use cutting-edge AI technology to discover and develop advanced …
Show more

Nuritas Frequently Asked Questions

  • When was Nuritas founded?

    Nuritas was founded in 2014.

  • Who are Nuritas key executives?

    Nuritas's key executives are Emmet Browne, Greg Staffor and Nora Khaldi.

  • How many employees does Nuritas have?

    Nuritas has 56 employees.

  • Who are Nuritas competitors?

    Competitors of Nuritas include ID R&D, GrAI Matter Labs and GTN.

  • Where is Nuritas headquarters?

    Nuritas headquarters is located at Hays House, 2 Dawson St, Dublin 2.

  • Where are Nuritas offices?

    Nuritas has an office in Dublin 2.

  • How many offices does Nuritas have?

    Nuritas has 1 office.